Anna Kathy Aman

Array ( [id] => 7756967 [patent_doc_number] => 20120028993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Compounds Effective Against Cancer' [patent_app_type] => utility [patent_app_number] => 13/144392 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8425 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028993.pdf [firstpage_image] =>[orig_patent_app_number] => 13144392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73363 [patent_doc_number] => 07749543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods useful in the treatment of bone resorption diseases' [patent_app_type] => utility [patent_app_number] => 12/351558 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3144 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749543.pdf [firstpage_image] =>[orig_patent_app_number] => 12351558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436228 [patent_doc_number] => 20090170815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'ALENDRONATE ORAL LIQUID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/342623 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4474 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170815.pdf [firstpage_image] =>[orig_patent_app_number] => 12342623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576113 [patent_doc_number] => 20090143475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/340355 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10178 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143475.pdf [firstpage_image] =>[orig_patent_app_number] => 12340355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599955 [patent_doc_number] => 07977384 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-07-12 [patent_title] => 'Anticancer tobacco cembranoids' [patent_app_type] => utility [patent_app_number] => 12/337617 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11986 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977384.pdf [firstpage_image] =>[orig_patent_app_number] => 12337617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271110 [patent_doc_number] => 20090074886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'GSK-3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/325828 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15632 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074886.pdf [firstpage_image] =>[orig_patent_app_number] => 12325828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380377 [patent_doc_number] => 20090192216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Methods for the formulation and manufacture of artesunic acid for injection' [patent_app_type] => utility [patent_app_number] => 12/315209 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5536 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192216.pdf [firstpage_image] =>[orig_patent_app_number] => 12315209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458117 [patent_doc_number] => 08293784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'α-amino acid derivatives for improving solubility' [patent_app_type] => utility [patent_app_number] => 12/745143 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13427 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127206 [patent_doc_number] => 08575155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Composition and method to modify sperm function and increase male gender ratio in mammals' [patent_app_type] => utility [patent_app_number] => 12/733928 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4945 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651900 [patent_doc_number] => 20110301169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Therapies for Treating Cancer Using Combinations of COX-2 Inhibitors and Antimetabolites' [patent_app_type] => utility [patent_app_number] => 13/131852 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26857 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301169.pdf [firstpage_image] =>[orig_patent_app_number] => 13131852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275615 [patent_doc_number] => 20100256117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'HEPATOCYTE GROWTH FACTOR PATHWAY ACTIVATORS IN FIBROTIC CONNECTIVE TISSUE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/734641 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29760 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256117.pdf [firstpage_image] =>[orig_patent_app_number] => 12734641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375330 [patent_doc_number] => 08258123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'C-19 steroids for cosmetic and further uses' [patent_app_type] => utility [patent_app_number] => 12/734621 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10231 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432150 [patent_doc_number] => 07968543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease' [patent_app_type] => utility [patent_app_number] => 12/267321 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 23515 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968543.pdf [firstpage_image] =>[orig_patent_app_number] => 12267321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6293078 [patent_doc_number] => 20100239688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND ANTI-TUMOR PLATINUM COMPLEX' [patent_app_type] => utility [patent_app_number] => 12/741682 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11627 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239688.pdf [firstpage_image] =>[orig_patent_app_number] => 12741682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410785 [patent_doc_number] => 20090124684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Stimulation Of CPT-1 As A Means To Reduce Weight' [patent_app_type] => utility [patent_app_number] => 12/266425 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5052 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124684.pdf [firstpage_image] =>[orig_patent_app_number] => 12266425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546806 [patent_doc_number] => 20090156683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'FAST RELEASE SOLID FORMULATION, PREPARATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/265297 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4065 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156683.pdf [firstpage_image] =>[orig_patent_app_number] => 12265297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265630 [patent_doc_number] => 20090118315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Methods of Treatment Using Sapacitabine' [patent_app_type] => utility [patent_app_number] => 12/265553 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12404 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118315.pdf [firstpage_image] =>[orig_patent_app_number] => 12265553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629994 [patent_doc_number] => 20100311689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMBINATION THERAPY WITH ORGANIC ARSENICALS' [patent_app_type] => utility [patent_app_number] => 12/740661 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4364 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311689.pdf [firstpage_image] =>[orig_patent_app_number] => 12740661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410793 [patent_doc_number] => 20090124692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR DECORPORATION OF RADIOACTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/260549 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4895 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124692.pdf [firstpage_image] =>[orig_patent_app_number] => 12260549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236829 [patent_doc_number] => 20100267785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'CANDESARTAN CILEXETIL' [patent_app_type] => utility [patent_app_number] => 12/740831 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2697 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267785.pdf [firstpage_image] =>[orig_patent_app_number] => 12740831 [rel_patent_id] =>[rel_patent_doc_number] =>)